Standard BioTools Price to Sales Ratio 2012-2026 | LAB
Historical PS ratio values for Standard BioTools (LAB) over the last 10 years. The current P/S ratio for Standard BioTools as of September 16, 2026 is .
| Standard BioTools P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-09-16 | 0.71 | 3.23 | |
| 2026-06-30 | 0.82 | $0.22 | 3.74 |
| 2026-03-31 | 0.92 | $0.23 | 4.09 |
| 2025-12-31 | 1.28 | $0.22 | 5.71 |
| 2025-09-30 | 1.30 | $0.16 | 7.91 |
| 2025-06-30 | 1.20 | $0.17 | 6.95 |
| 2025-03-31 | 1.08 | $0.18 | 6.14 |
| 2024-12-31 | 1.75 | $0.28 | 6.31 |
| 2024-09-30 | 1.93 | $0.63 | 3.06 |
| 2024-06-30 | 1.77 | $0.89 | 1.98 |
| 2024-03-31 | 2.71 | $1.18 | 2.29 |
| 2023-12-31 | 2.21 | $1.35 | 1.64 |
| 2023-09-30 | 2.90 | $1.33 | 2.17 |
| 2023-06-30 | 1.93 | $1.34 | 1.44 |
| 2023-03-31 | 1.95 | $1.23 | 1.59 |
| 2022-12-31 | 1.17 | $1.26 | 0.93 |
| 2022-09-30 | 1.10 | $1.42 | 0.78 |
| 2022-06-30 | 1.60 | $1.46 | 1.09 |
| 2022-03-31 | 3.59 | $1.63 | 2.20 |
| 2021-12-31 | 3.92 | $1.73 | 2.27 |
| 2021-09-30 | 6.59 | $1.84 | 3.58 |
| 2021-06-30 | 6.16 | $2.02 | 3.05 |
| 2021-03-31 | 4.52 | $1.98 | 2.29 |
| 2020-12-31 | 6.00 | $1.93 | 3.11 |
| 2020-09-30 | 7.43 | $1.80 | 4.14 |
| 2020-06-30 | 4.01 | $1.63 | 2.47 |
| 2020-03-31 | 2.54 | $1.67 | 1.52 |
| 2019-12-31 | 3.48 | $1.79 | 1.94 |
| 2019-09-30 | 4.63 | $2.12 | 2.18 |
| 2019-06-30 | 12.32 | $2.48 | 4.97 |
| 2019-03-31 | 13.29 | $2.75 | 4.84 |
| 2018-12-31 | 8.62 | $2.88 | 2.99 |
| 2018-09-30 | 7.49 | $2.91 | 2.58 |
| 2018-06-30 | 5.96 | $2.89 | 2.07 |
| 2018-03-31 | 5.84 | $3.02 | 1.93 |
| 2017-12-31 | 5.89 | $3.25 | 1.81 |
| 2017-09-30 | 5.04 | $3.27 | 1.54 |
| 2017-06-30 | 4.04 | $3.32 | 1.22 |
| 2017-03-31 | 5.69 | $3.47 | 1.64 |
| 2016-12-31 | 7.28 | $3.61 | 2.02 |
| 2016-09-30 | 8.01 | $3.81 | 2.10 |
| 2016-06-30 | 9.03 | $4.04 | 2.23 |
| 2016-03-31 | 8.07 | $4.06 | 1.99 |
| 2015-12-31 | 10.81 | $4.00 | 2.70 |
| 2015-09-30 | 8.11 | $4.13 | 1.96 |
| 2015-06-30 | 24.20 | $4.19 | 5.77 |
| 2015-03-31 | 42.10 | $4.19 | 10.05 |
| 2014-12-31 | 33.73 | $4.20 | 8.02 |
| 2014-09-30 | 24.50 | $3.82 | 6.42 |
| 2014-06-30 | 29.40 | $3.48 | 8.45 |
| 2014-03-31 | 44.07 | $3.18 | 13.86 |
| 2013-12-31 | 38.28 | $2.80 | 13.68 |
| 2013-09-30 | 21.94 | $2.69 | 8.17 |
| 2013-06-30 | 17.46 | $2.54 | 6.88 |
| 2013-03-31 | 18.51 | $2.48 | 7.46 |
| 2012-12-31 | 14.31 | $2.44 | 5.86 |
| 2012-09-30 | 17.00 | $2.46 | 6.90 |
| 2012-06-30 | 15.04 | $2.42 | 6.21 |
| 2012-03-31 | 15.73 | $2.32 | 6.77 |
| 2011-12-31 | 13.16 | $2.59 | 5.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.271B | $0.085B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| 10x Genomics (TXG) | United States | $9.692B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Hims & Hers Health (HIMS) | United States | $6.498B | 0.00 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.157B | 32.86 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |